Delivery Order SPE2DX15D1104-SPE2DX23F3VB9
Award Date 8/7/23
Potential Completion Date 8/28/23
Potential Value $846
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $5,075.88 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply ZOLADEX 10.8 MG IMPLANT SYRNS. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by December 12, 2023. No set-aside designation was applied to this award made under the prime vendor's existing pharmaceutical distribution...
- The Defense Logistics Agency awarded a $8,459.80 firm fixed price delivery order to Amerisourcebergen Drug Corp for ZOLADEX 10.8 MG IMPLANT SYRNS. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the location of performance in Conshohocken, Pennsylvania by August 7, 2023. The parent company of the prime, Amerisourcebergen Corporation, will support delivery under this order issued against an existing DLA contract vehicle. No subcontractors...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.82 to AmerisourceBergen Drug Corp for ZOLADEX 3.6 mg implant syringes, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,592.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZOLADEX 3.6 MG implant syringes, with an ultimate completion date of February 13, 2026. This non-set-aside contract was awarded competitively on January 23, 2026, with performance to be executed from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.24 to AmerisourceBergen Drug Corp for the supply of ZOLADEX 10.8 mg implant syringes under a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and is scheduled for completion by January 5, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZOLADEX 3.6 mg implant syringes under a firm fixed price contract valued at $1,323.88. This non-set-aside award, issued on July 31, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $20,186 delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 6, 2026. This firm fixed-price, non-set-aside contract represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D1053|SPE2DX24F6KLE) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit parent company Cencora, Inc. The $8,772.80 contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS medical supplies, with a completion date of May 1, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.80 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 26, 2026. This is a firm fixed-price, non-set-aside contract executed on February 4, 2026, with performance taking place at the awardee's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.88 to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is...